3-acetylpyridine has been researched along with Alloxan Diabetes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrios, V; Berciano, J; Busiguina, S; Clark, R; Fernandez, AM; Tolbert, DL; Torres-Aleman, I | 1 |
1 trial(s) available for 3-acetylpyridine and Alloxan Diabetes
Article | Year |
---|---|
Neurodegeneration is associated to changes in serum insulin-like growth factors.
Topics: Adolescent; Adult; Aged; Animals; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cerebellar Ataxia; Cerebellum; Charcot-Marie-Tooth Disease; Child; Child, Preschool; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; DNA-Binding Proteins; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor I; Middle Aged; Myelin Proteins; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Mutant Strains; Tumor Suppressor Proteins | 2000 |